Children's Hospital Colorado has unveiled a pioneering Sublingual Immunotherapy (SLIT) Program at its Anschutz Medical Campus in Aurora, offering an advanced and expanded range of therapeutic solutions for pediatric patients with specific food sensitivities. This initiative empowers eligible young individuals to access ongoing treatment designed to cultivate increased tolerance to a spectrum of up to ten food allergens through a regimen of daily liquid drops, meticulously developed by Top9Proteins.
Participants in this specialized program initially attend four supervised sessions at the Children's Colorado Food Challenge and Research Unit. During these visits, they receive precisely controlled, minute quantities of allergens administered sublingually. Following this introductory phase, families transition to a daily at-home treatment plan. Adherence to this consistent daily routine is anticipated to progressively enhance the child's tolerance and offer a more robust defense against inadvertent exposure to allergens.
The newly launched Sublingual Immunotherapy Program at Children's Colorado is designed to address a variety of common allergies, including those to milk, egg, peanut, cashew (which also confers protection against pistachio), walnut (also providing coverage for pecan), almond, hazelnut, and sesame. Future plans include the potential incorporation of additional allergens such as soy and wheat. While children of all age groups may be considered for enrollment, clinical observations suggest that younger patients often exhibit a more favorable response to immunotherapy, potentially experiencing more pronounced and beneficial outcomes.
The journey into the program commences with a comprehensive evaluation conducted by a Children's Colorado allergist. Should a patient be deemed suitable, they will subsequently be referred for a virtual immunotherapy consultation. This consultation serves as a crucial platform for families to explore the full array of available treatment modalities, encompassing both sublingual immunotherapy and oral immunotherapy. Collaborating with their dedicated care team, families can then collectively determine the most appropriate and personalized treatment trajectory. It is important to note that appointment scheduling may entail varying wait times, potentially ranging from several weeks to a few months.
The Allergy and Immunology Center at Children's Colorado stands as one of the nation's largest facilities dedicated to managing allergic and immunologic disorders in pediatric populations. Furthermore, it distinguishes itself as one of the few regional pediatric medical centers providing sublingual immunotherapy. While this therapeutic approach has yet to receive FDA approval for this specific application, qualified patients can obtain necessary prescriptions via Children's Colorado's outpatient pharmacy. The most frequently reported adverse effect associated with SLIT is a transient itching sensation in the mouth. It is crucial to understand that while sublingual immunotherapy can significantly mitigate the likelihood and severity of allergic reactions, it does not constitute a complete cure and therefore does not negate the continued necessity for diligent allergy precautions.